Why the study?
Does long-term treatment with procaine amide cause drug-induced SLE syndrome in patients with cardiac arrhythmias?
Does long-term treatment with procaine amide cause drug-induced SLE syndrome in patients with cardiac arrhythmias?
Long-term procaine amide therapy frequently induces ANF and SLE syndrome, particularly in slow acetylators, which typically resolves upon discontinuation.
Answers are grounded in this paper and cite their sources.
Monitoring for drug-induced SLE warranted with long-term procaine amide, especially in slow acetylators; supports acetylator phenotyping research but leaves practice implications open.
Abstract.During 1970–75 a total of 42 patients have been subjected to long‐term treatment with procaine amide (PrA) because of different cardiac arrhythmias and have been observed up to over 5 years. Among these patients 35 (83%) developed a significantly increased titer of ANF and of these, 12 patients (29%) developed a “classical” drug‐induced SLE syndrome. In the SLE group all but 2 improved rapidly after cessation of PrA, and the ANF titer decreased continuously but slowly in both groups. Acetylation test with sulphamidine and/or isoniazid in 11 patients among the SLE cases showed 8 slow and 3 fast acetylators. Among 12 patients who also had received PrA for a long time, but had not shown any signs of an SLE syndrome, there were 10 fast and 2 slow acetylators.
No takes yet. Share an insight, caveat, or question.
Henningsen et al. (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: